Which has grown faster, INCY or MRNA?

Over the past five years, MRNA grew revenue faster — INCY at a 16.43% CAGR versus MRNA at 19.33%.

Is INCY or MRNA more profitable?

INCY runs the higher net margin — INCY at 27.71% versus MRNA at -141.43%.

How have INCY and MRNA total returns compared?

Over the past 5 years, INCY delivered 2.87% and MRNA delivered -32.21% annualized total return. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Incyte Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 9, 2026. Differences are shown without an overall score or investment verdict.

INCY

Incyte Corporation

$24.44B

$120.56HealthcareAt close: Aug 7, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$23.48B

$59.17HealthcareAt close: Aug 7, 2026, 4:00 PM ET

Total return — INCY vs MRNA

growth of $100 · dividends reinvested · last 8y

INCY +86.9%MRNA +218.1%MRNA compounded faster

INCY MRNA

INCY vs MRNA: by the numbers

•INCY is the larger company ($24.44B vs $23.48B market cap).
•INCY is profitable (27.71% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 16.43% CAGR).

Metrics side by side

Valuation

Metric	INCY	MRNA
P/E ratio	15.36	N/A
Forward P/E	28.83	N/A
P/S ratio	4.31	10.52
P/B ratio	3.96	3.47
PEG ratio	0.72	N/A
EV / EBITDA	10.93	N/A
FCF yield	7.65%	N/A

Profitability

Metric	INCY	MRNA
Gross margin	92.62%	55.35%
Operating margin	31.57%	-158.13%
Net margin	27.71%	-141.43%
ROE	25.41%	-46.61%
ROIC	20.58%	-29.70%

Growth (annualized)

Metric	INCY	MRNA
Revenue CAGR (5Y)	16.43%	19.33%
EPS CAGR (5Y)	21.19%	N/A
FCF CAGR (5Y)	33.69%	N/A
Total return CAGR (5Y)	9.58%	-32.21%

Frequently asked

Which has grown faster, INCY or MRNA?: Over the past five years, MRNA grew revenue faster — INCY at a 16.43% CAGR versus MRNA at 19.33%.
Is INCY or MRNA more profitable?: INCY runs the higher net margin — INCY at 27.71% versus MRNA at -141.43%.
How have INCY and MRNA total returns compared?: Over the past 5 years, INCY delivered 2.87% and MRNA delivered -32.21% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio Moderna P/E ratio Incyte dividend yield Moderna dividend yield Incyte ROE Moderna ROE Incyte operating margin Moderna operating margin Incyte revenue growth Moderna revenue growth Incyte free cash flow Moderna free cash flow

Incyte & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 9, 2026.